Tuesday, May 21, 2019

Medical Marijuana Market Overview, Industry Top Manufactures, Size, Growth 2018-2026

Medical application of marijuana as pain management in cancer, seizures, neurology, and muscle spasm will drive the market growth.
Market Size – USD 11.70 Billion in 2018, Market Growth - CAGR of 26.4%, Market Trends – Legalization of marijuana in several countries.
The Global Medical Marijuana Market is forecast to reach USD 148.35 Billion by 2026, according to a new report by Reports and Data.  Marijuana is used for treating chronic pain that affects millions of people each year across the globe, thus increasing the demand for the product as a treatment procedure for medical conditions. Statistically, around 25 million people endure acute pain in the US. Moreover, several countries around the globe have made medical marijuana legal, i.e., it would allow people to use marijuana for health purposes; therefore, boosting the market for the medical marijuana market.

Side effects of the products include dizziness, fatigue, speech problem, constipation, and insomnia will hamper the growth of the market. Additionally, lack of data safety and problem in undertaking medical marijuana business is also estimated to hinder the growth of the market.
In 2017, Oxford University went into a partnership with Kingsley Capital Partners, for the development of cannabis treatment for inflammatory and cancer diseases. These partnerships are expected to have a positive impact on the market of medical marijuana.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-medical-marijuana-market
Further key findings from the report suggest
  • Countries are beginning to liberalize laws related to medical marijuana; the market is forecasted to witness a surge in demand. Statistically, the majority of the cannabis, are currently, sold through illicit channels.
  • Several countries have recognized the advantages of this product and are in the process of legalizing it.
  • With a rise in the volume of clinical trials and scientific studies, the demand for cannabis for clinical use is forecasted to grow over the forecast period. Medical marijuana held a market share of 53% in the year 2018.
  • Countries in North America have also started promoting derivatives such as oils, tinctures, and resins, along with products like vaporizers, among millennial’s who are considered primary consumers.
  • The oil segment is forecasted to grow with the highest CAGR of 27.1% in the forecast period. Hemp oil is in high demand among healthcare sector for clinical purposes.
  • Dispensaries held a market share of 48% in the year 2018. These pharmacies sell various legal cannabis products in the form of tablets, vaporizers, balms, elixirs, and tinctures.
  • Patients usually prefer buying medical products from authorized and legal sources to abide by the government’s rules, thus maximizing the revenue by this segment.
  • Europe is forecasted to have a market share of 28% in the year 2026. Germany is the largest market for cannabis and thereby fuels the growth of the market in this region.
  • Key participants Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., ABcann Medicinals, Inc., Tikun Olam, Insys Therapeutics, Inc., The Peace Naturals Project, MedReleaf Corporation, and GW Pharmaceuticals PLC.
For the purpose of this report, Reports and Data have segmented the global Medical Marijuana Market on the basis of Marijuana Type, Product Type, Route of Administration, Distribution Channel, Medical Application, and Region:
Marijuana Type Outlook (Revenue, USD Billion; 2016-2026)
  • Medical Marijuana
  • Recreational Marijuana
Product Type Outlook (Revenue, USD Billion; 2016-2026)
  • Oil
  • Buds
  • Tinctures
Medical Application Outlook (Revenue, USD Billion; 2016-2026)
  • Chronic Pain
  • Mental Disorders
  • Anorexia
  • Seizures
  • Muscle Spasm
  • Cancer
  • Others
Route of Administration Outlook (Revenue, USD Billion; 2016-2026)
  • Inhalation
  • Oral
  • Intravenous
  • Topical
Distribution Channel Outlook (Revenue, USD Billion; 2016-2026)
  • Dispensaries
  • Online
Regional Outlook (Revenue, USD Billion; 2016-2026)
  • North America
    • U.S.
  • Europe
    • UK
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • MEA
    • Latin America
  • Brazil
Request For Free PDF Sample of This Research Report at: https://www.reportsanddata.com/sample-enquiry-form/1413 

No comments:

Post a Comment

The Alarming Increase in Incidences of Stroke is Boosting the Adoption of Neurovascular Devices

Neurovascular disorders are the second most leading causes of death worldwide after heart diseases. Statistical data suggest a high number o...